1.
Chen G, Herr M, Nowak J, Ho C, Almyroudis N, Attwood K, Bonnewell J, Walsh M, Segal B, Ross M, McCarthy P, Hahn T. Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant. Haematologica 2023;108(2):615-620; https://doi.org/10.3324/haematol.2022.281719.